Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGF19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | CHKB-CPT1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MFSD5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | EML5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | HSPA5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | NLGN3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | SPRYD7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | FBXO11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | TLE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | GPRC5D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |